That April 9th PR also said. "The Company is no
Post# of 72440
"The Company is now positioning itself to further advance Brilacidin, most immediately, in its planned Phase 3 Oral Mucositis program, and in mid-stage testing for Inflammatory Bowel Disease."
5 weeks?? I know I know bobbleheads "most immediately" meant in Biotech Time....LOL